Ideal Biosciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 2 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 0.90 M
- Revenue Growth -41.31%
- Profit Growth -19.19%
- Ebitda -41.48%
- Net Worth 21.21%
- Total Assets -26.36%
About Ideal Biosciences
Ideal Biosciences Private Limited (IBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 15 November 2017 (Seven years and two months 25 days old ). Its registered office is in Manaparai Taluk, Tamil Nadu.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.90 M.
Palanisamy Iyapparaj, Sesuraj Divakar, and Niroshan serve as directors at the Company.
Company Details
-
LocationManaparai Taluk, Tamil Nadu
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999TN2017PTC119535
-
Company No.
119535
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Nov 2017
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Ideal Biosciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Palanisamy Iyapparaj
|
Director | 15-Nov-2017 | Current |
|
Sesuraj Divakar
|
Director | 15-Nov-2017 | Current |
|
Niroshan
|
Director | 05-Aug-2021 | Current |
Financial Performance of Ideal Biosciences.
Ideal Biosciences Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 41.31% decrease. The company also saw a substantial fall in profitability, with a 19.19% decrease in profit. The company's net worth Soared by an impressive increase of 21.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ideal Biosciences?
In 2021, Ideal Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Amoga Biologics Private LimitedPalanisamy Iyapparaj is a mutual person
Charges (Loans)
₹0.90 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 0.09 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 May 2023 | Bank Of India | ₹0.90 M | Open |
How Many Employees Work at Ideal Biosciences?
Unlock and access historical data on people associated with Ideal Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ideal Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ideal Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
